Episurf Medical reaches important regulatory milestone in India
Episurf Medical (Nasdaq: EPIS B) today announces that the Indian authorities have, through their Directorate General of Health Services, Central Drugs Standard Control Organisation (CDSCO), Medical Devices Division, confirmed that the Episealer® Knee implant portfolio represents a Custom Made device that can be imported to India in accordance with the rules for Custom Made devices. This classification follows a review process, and represents an important regulatory milestone for Episurf Medical, as it enables a market expansion in the Indian market. Episurf Medical has been targeting the